Suppr超能文献

结节性多动脉炎和腺苷脱氨酶 2 缺乏症——相隔几代的共同谱系。

Polyarteritis nodosa and deficiency of adenosine deaminase 2 - Shared genealogy, generations apart.

机构信息

Department of Rheumatology and Immunology, Guangdong Second Provincial General Hospital, Guangzhou, China; Division of Rheumatology, Inflammation and Immunity, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.

Department of Rheumatology and Immunology, Guangdong Second Provincial General Hospital, Guangzhou, China.

出版信息

Clin Immunol. 2020 Jun;215:108411. doi: 10.1016/j.clim.2020.108411. Epub 2020 Apr 7.

Abstract

Polyarteritis nodosa (PAN) is a systemic necrotizing vasculitis that predominantly affects medium-sized arteries. With the establishment and refinement of vasculitis nomenclature and diagnostic criteria, clinical findings of PAN and distinguishing features from other vasculitides are now well characterized. Although PAN typically manifests in adulthood, cohort studies in paediatric patients have shaped our understanding of childhood-onset PAN. The paradigm of childhood-onset PAN changed considerably with the landmark discovery of deficiency of ADA2 (DADA2), a monogenic cause of vasculitis that is often indistinguishable from PAN. Testing for DADA2 has provided an explanation to numerous challenging cases of familial PAN and early-onset PAN around the world. The ability to distinguish DADA2 from classic PAN have important therapeutic implications as tumor necrosis factor inhibitors have demonstrated remarkable efficacy in the treatment of DADA2. In this review, we will discuss our current understanding of PAN and DADA2 and highlight similarities and differences between these vasculitides.

摘要

结节性多动脉炎(PAN)是一种系统性坏死性血管炎,主要影响中等大小的动脉。随着血管炎命名法和诊断标准的确立和完善,PAN 的临床发现及其与其他血管炎的鉴别特征现在已得到很好的描述。虽然 PAN 通常发生在成年期,但儿科患者的队列研究改变了我们对儿童发病的 PAN 的认识。随着 ADA2(DADA2)缺陷这一血管炎的单基因病因的重要发现,儿童发病的 PAN 的模式发生了很大变化,这种疾病通常与 PAN 无法区分。DADA2 的检测为世界各地众多具有挑战性的家族性 PAN 和早发性 PAN 病例提供了病因解释。能够将 DADA2 与经典 PAN 区分开来具有重要的治疗意义,因为肿瘤坏死因子抑制剂在治疗 DADA2 方面已显示出显著疗效。在这篇综述中,我们将讨论我们目前对 PAN 和 DADA2 的理解,并强调这两种血管炎之间的相似性和差异。

相似文献

3
Polyarteritis nodosa: an evolving primary systemic vasculitis.结节性多动脉炎:一种不断演变的原发性系统性血管炎。
Postgrad Med. 2023 Jan;135(sup1):61-68. doi: 10.1080/00325481.2022.2088940. Epub 2022 Jun 22.
8
Systematic review of childhood-onset polyarteritis nodosa and DADA2.儿童发病型结节性多动脉炎与 DADA2 的系统综述
Semin Arthritis Rheum. 2021 Jun;51(3):559-564. doi: 10.1016/j.semarthrit.2021.04.009. Epub 2021 Apr 19.
9
Deficiency of Adenosine Deaminase 2: Clinical Manifestations, Diagnosis, and Treatment.腺苷脱氨酶2缺乏症:临床表现、诊断与治疗
Rheum Dis Clin North Am. 2023 Nov;49(4):773-787. doi: 10.1016/j.rdc.2023.06.004. Epub 2023 Aug 1.

引用本文的文献

5
Cutaneous vasculitis in autoinflammatory diseases.自身炎症性疾病中的皮肤血管炎。
J Dermatol. 2024 Feb;51(2):150-159. doi: 10.1111/1346-8138.17030. Epub 2023 Nov 13.
9
A Cohort Study on Deficiency of ADA2 from China.中国 ADA2 缺乏症的队列研究。
J Clin Immunol. 2023 May;43(4):835-845. doi: 10.1007/s10875-023-01432-8. Epub 2023 Feb 18.
10
Editorial: DADA2 and other monogenic vasculitides.社论:DADA2及其他单基因血管炎
Front Immunol. 2022 Dec 8;13:1108853. doi: 10.3389/fimmu.2022.1108853. eCollection 2022.

本文引用的文献

7
Treatment Strategies for Deficiency of Adenosine Deaminase 2.腺苷脱氨酶2缺乏症的治疗策略
N Engl J Med. 2019 Apr 18;380(16):1582-1584. doi: 10.1056/NEJMc1801927.
8
Infliximab for the treatment of refractory polyarteritis nodosa.英夫利昔单抗治疗难治性结节性多动脉炎。
Clin Rheumatol. 2019 Oct;38(10):2825-2833. doi: 10.1007/s10067-019-04474-9. Epub 2019 Apr 10.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验